Results Based Coaching, located in Richland, WA, provides adults 40 and older using semaglutide or other GLP-1 medications with a structured resistance-training and nutrition-coaching protocol. This program is designed to preserve lean muscle mass, protect metabolic rate, and ensure that weight lost while on medication comes primarily from fat, not functional strength.
Rapid weight loss achieved through semaglutide and other GLP-1 medications does not distinguish between fat and muscle. Without a deliberate resistance-training intervention, a significant share of total weight lost is lean tissue.
Clinical research on GLP-1 receptor agonists indicates that a substantial portion of weight lost during treatment can come from lean muscle mass when resistance training is absent. Reduced appetite and lower overall caloric intake, combined with inactivity, accelerate this decline.
Losing muscle alongside fat produces a condition sometimes described as sarcopenic weight loss: a lighter body composed of a higher percentage of fat relative to lean tissue. This outcome undermines long-term strength, mobility, and the visible "toned" result most clients are seeking.
Muscle tissue is metabolically active; it is a primary driver of resting energy expenditure. Preserving lean mass during weight loss helps protect metabolic rate, reducing the likelihood of rebound weight regain once medication dosing is adjusted or discontinued.
Coaches at Results Based Coaching structure each GLP-1 client's program around three evidence-based pillars, adjusted to individual mobility, medical history, and tolerance.
Clients are guided toward a daily protein intake of approximately 0.8 to 1 gram per pound of bodyweight, distributed across meals to offset the appetite suppression common with GLP-1 medications and to supply the building blocks required for muscle retention.
Programming is centered on compound movement patterns, including squats, deadlifts, rows, and bench press variations, performed at an intensity sufficient to signal the body to retain muscle rather than metabolize it for energy.
Coaches log load, repetitions, and effort at every session, incrementally increasing training demand as recovery and appetite allow. This tracked progression is documented and reviewed at each check-in to confirm strength is being maintained or improved throughout the weight loss phase.
Clients following this protocol are tracked through periodic body composition scans, allowing coaches and clients to confirm that weight lost is predominantly fat mass rather than lean tissue.
"My InBody scans showed I kept nearly all of my muscle while the number on the scale kept dropping. My coach adjusted my protein and lifting plan every two weeks so my strength never suffered."
— GLP-1 Program Client, Richland, WA
"I was worried semaglutide would leave me weaker. Instead, my squat and deadlift numbers went up while I lost over thirty pounds of fat. The compound lifting program made the difference."
— GLP-1 Program Client, Tri-Cities, WA
Every semaglutide and GLP-1 client follows a structured, coach-supervised sequence designed to establish a baseline and hold clients accountable to their muscle-preservation targets.
A baseline body composition scan establishes starting lean mass, fat mass, and metabolic rate, giving coaches an objective reference point for every future comparison.
Protein intake targets and meal timing guidance are integrated directly into the client's coaching plan to counteract appetite suppression from GLP-1 medication.
Coaches design and adjust a weekly compound-lift schedule, tracking load and repetitions to confirm progressive overload continues throughout the weight loss phase.
Follow-up InBody scans and coaching reviews occur every two weeks to confirm muscle retention, adjust protein and training targets, and document measurable progress.
Common questions from clients using semaglutide or other GLP-1 medications.
Semaglutide itself does not directly cause sarcopenia, but the rapid weight loss and reduced caloric intake associated with GLP-1 medications can accelerate muscle loss when resistance training and adequate protein intake are absent. A structured strength program is the primary countermeasure recommended by our coaching staff.
Most clients are guided toward approximately 0.8 to 1 gram of protein per pound of bodyweight daily, spread across two to four meals or snacks to accommodate reduced appetite. Individual targets are set in coordination with each client's nutrition coach and medical provider.
Training intensity must be sufficient to challenge major muscle groups, typically requiring compound lifts performed near, but within, a client's safe capacity. Coaches calibrate load and volume individually and progress intensity gradually as strength and recovery capacity allow.
Resistance training does not interact directly with GLP-1 medications, but clients may experience reduced energy or appetite that affects training tolerance. Coaches adjust session intensity and frequency accordingly, and clients are encouraged to coordinate any new exercise program with their prescribing physician.
Measurable changes in body composition are typically visible within the first four to six weeks through biweekly InBody scans. Consistent adherence to the protein target and weekly compound-lifting schedule is the primary driver of results within this timeframe.
No. This program is designed for adults 40 and older regardless of prior training history. Coaches begin every client with a movement assessment and introduce compound lifting patterns at a pace suited to individual mobility and comfort.